# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Chimera Investment (NYSE:CIM) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0....
UBS analyst Douglas Harter maintains Chimera Investment (NYSE:CIM) with a Buy and raises the price target from $15 to $16.
Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the...
HomeXpress Mortgage Corp. ("HomeXpress"), a leading national originator of non-QM and business-purpose residential mort...
Chimera Investment Corp (CIM) to acquire HomeXpress Mortgage Corp for $120M in cash and stock. Deal to expand mortgage loan ori...